472 related articles for article (PubMed ID: 33165869)
1. Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles.
Grego EA; Siddoway AC; Uz M; Liu L; Christiansen JC; Ross KA; Kelly SM; Mallapragada SK; Wannemuehler MJ; Narasimhan B
Curr Top Microbiol Immunol; 2021; 433():29-76. PubMed ID: 33165869
[TBL] [Abstract][Full Text] [Related]
2. Nanovaccine: A novel approach in immunization.
Gheibi Hayat SM; Darroudi M
J Cell Physiol; 2019 Aug; 234(8):12530-12536. PubMed ID: 30633361
[TBL] [Abstract][Full Text] [Related]
3. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
[TBL] [Abstract][Full Text] [Related]
4. pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.
Wilson JT; Keller S; Manganiello MJ; Cheng C; Lee CC; Opara C; Convertine A; Stayton PS
ACS Nano; 2013 May; 7(5):3912-25. PubMed ID: 23590591
[TBL] [Abstract][Full Text] [Related]
5. Novel adjuvants & delivery vehicles for vaccines development: a road ahead.
Mohan T; Verma P; Rao DN
Indian J Med Res; 2013 Nov; 138(5):779-95. PubMed ID: 24434331
[TBL] [Abstract][Full Text] [Related]
6. Nanovaccine: an emerging strategy.
Das A; Ali N
Expert Rev Vaccines; 2021 Oct; 20(10):1273-1290. PubMed ID: 34550859
[TBL] [Abstract][Full Text] [Related]
7. Self-adjuvanting cancer nanovaccines.
Liao Z; Huang J; Lo PC; Lovell JF; Jin H; Yang K
J Nanobiotechnology; 2022 Jul; 20(1):345. PubMed ID: 35883176
[TBL] [Abstract][Full Text] [Related]
8. Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens.
Lin SY; Yao BY; Hu CJ; Chen HW
Int J Nanomedicine; 2020; 15():3303-3318. PubMed ID: 32494131
[TBL] [Abstract][Full Text] [Related]
9. Self-Adjuvanting Polyguanidine Nanovaccines for Cancer Immunotherapy.
Zhang X; Wang K; Zhao Z; Shan X; Wang Y; Feng Z; Li B; Luo C; Chen X; Sun J
ACS Nano; 2024 Mar; 18(9):7136-7147. PubMed ID: 38407021
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology in vaccine delivery.
Peek LJ; Middaugh CR; Berkland C
Adv Drug Deliv Rev; 2008 May; 60(8):915-28. PubMed ID: 18325628
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
Jin JW; Tang SQ; Rong MZ; Zhang MQ
Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
[TBL] [Abstract][Full Text] [Related]
12. A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy.
Zhao Z; Hu Y; Hoerle R; Devine M; Raleigh M; Pentel P; Zhang C
Nanomedicine; 2017 Feb; 13(2):443-454. PubMed ID: 27520729
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticulate Carriers Used as Vaccine Adjuvant Delivery Systems.
Wang N; Qian R; Liu T; Wu T; Wang T
Crit Rev Ther Drug Carrier Syst; 2019; 36(5):449-484. PubMed ID: 32421952
[TBL] [Abstract][Full Text] [Related]
14. Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccine.
Liu X; Min Q; Song H; Yue A; Li Q; Zhou Q; Han W
J Nanobiotechnology; 2023 Nov; 21(1):441. PubMed ID: 37993870
[TBL] [Abstract][Full Text] [Related]
15. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
16. A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses
Yoshioka Y; Kobiyama K; Hayashi T; Onishi M; Yanagida Y; Nakagawa T; Hashimoto M; Nishinaka A; Hirose J; Asaoka Y; Tajiri M; Hayata A; Ishida S; Omoto S; Nagira M; Ishii KJ
Front Immunol; 2023; 14():1116238. PubMed ID: 36891311
[TBL] [Abstract][Full Text] [Related]
17. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
Front Immunol; 2018; 9():783. PubMed ID: 29720976
[TBL] [Abstract][Full Text] [Related]
18. The quest for nanoparticle-powered vaccines in cancer immunotherapy.
Sun Z; Zhao H; Ma L; Shi Y; Ji M; Sun X; Ma D; Zhou W; Huang T; Zhang D
J Nanobiotechnology; 2024 Feb; 22(1):61. PubMed ID: 38355548
[TBL] [Abstract][Full Text] [Related]
19. Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction.
Zhao Z; Harris B; Hu Y; Harmon T; Pentel PR; Ehrich M; Zhang C
Biomaterials; 2018 Feb; 155():165-175. PubMed ID: 29179132
[TBL] [Abstract][Full Text] [Related]
20. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
